» Articles » PMID: 17191195

Prevalence of Retinitis Pigmentosa in Urban and Rural Adult Chinese: The Beijing Eye Study

Overview
Specialty Ophthalmology
Date 2006 Dec 28
PMID 17191195
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the prevalence of retinitis pigmentosa in the elderly Chinese population.

Methods: The Beijing Eye Study is a population-based, cross-sectional cohort study and included 4439 subjects out of 5324 subjects invited to participate (response rate 83.4%) with an age of 40+ years. Readable fundus photographs were available for 4027 (90.7%) subjects. Diagnostic criteria for retinitis pigmentosa were visual field defects on frequency doubling perimetry, typical ophthalmoscopic abnormalities such as retinal pigment deposits, retinal arteriole attenuation, and pigment epithelial atrophy, and no other reason for perimetric defects and fundus abnormalities.

Results: Retinitis pigmentosa was diagnosed in four subjects (all men). Its prevalence was 0.099+/-3.15% (95% CI: 0.00, 0.2).

Conclusions: Retinitis pigmentosa with typical fundus appearance and functional loss may be present in about 1 out of 1000 elderly Chinese in Northern China. Calculated for the whole population in China, the figure would be 1.3 million patients with retinitis pigmentosa.

Citing Articles

Bilateral angle closure glaucoma with retinitis pigmentosa in young patients: case series.

Lu Z, Wang L, Ying X, Tan L BMC Ophthalmol. 2023; 23(1):458.

PMID: 37968604 PMC: 10648655. DOI: 10.1186/s12886-023-03190-y.


Prevalence of inherited retinal diseases in a large Egyptian cohort.

Tawfik C, Roshdy M, Morris N BMC Ophthalmol. 2023; 23(1):422.

PMID: 37864132 PMC: 10588215. DOI: 10.1186/s12886-023-03163-1.


A novel pathogenic splicing mutation of in a Chinese family with X-linked retinitis pigmentosa verified by minigene splicing assay.

Wang H, Cong P, He T, Yu X, Huo Y Int J Ophthalmol. 2023; 16(10):1595-1600.

PMID: 37854381 PMC: 10559041. DOI: 10.18240/ijo.2023.10.06.


Allele-specific gene-editing approach for vision loss restoration in -associated retinitis pigmentosa.

Liu X, Qiao J, Jia R, Zhang F, Meng X, Li Y Elife. 2023; 12.

PMID: 37272616 PMC: 10279453. DOI: 10.7554/eLife.84065.


Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.

Nguyen X, Moekotte L, Plomp A, Bergen A, van Genderen M, Boon C Int J Mol Sci. 2023; 24(8).

PMID: 37108642 PMC: 10139437. DOI: 10.3390/ijms24087481.